# Progress Note 05 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Audre Lorde (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML016-SYN
- Date: 2026-10-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Naomi Fairweather, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day; HCPCS Q0091 (collection of a screening Papanicolaou smear)

## Chief complaint

Adult preventive visit; no new complaints. **S**

## History of present illness

Ms. Lorde comes for her yearly preventive visit, three weeks after her one-year survivorship visit. She is thirteen months from a right mastectomy for stage IA hormone receptor-positive breast cancer and has taken tamoxifen daily for a year. Her left mammogram four weeks ago was normal. She saw the genetic counselor two weeks ago, and the panel result is expected in about two weeks. Her hot flashes are mild and settled with the cooling measures she has used since the spring. Her periods come every 28 to 35 days and are lighter than before tamoxifen, with no bleeding between periods. She walks most days and is writing well. She completed the health risk assessment before the visit. **S**

| Element | Detail |
|---|---|
| Visit | Adult preventive visit, age 45 |
| Active conditions | Stage IA right breast cancer after mastectomy, on adjuvant tamoxifen |
| Medicines | Tamoxifen 20 mg daily |
| Gynecologic | Cycles every 28 to 35 days, lighter; no intermenstrual or postcoital bleeding |
| Functional status | Independent; walking about 200 minutes a week |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good |
| Psychosocial | Close family and a wide circle of friends and fellow writers; no financial strain; feels safe at home |
| Behavioral | Never smoker; a glass of wine a few times a month; walks most days; cooks most meals with vegetables and whole grains |
| Activities of daily living | Independent in all |
| Instrumental activities of daily living | Manages her own medicines, money, travel, and household |
| Home safety | Smoke detectors working; wears a seat belt; no firearms in the home |
| Hearing and vision | Reading glasses; eye examination last year; no hearing concern |
| Sleep | About seven hours a night; hot flashes wake her about once a week |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, night sweats, or unexplained tiredness |
| Eyes | Negative | No change in vision; no floaters |
| Ears, nose, mouth, and throat | Negative | No hearing change or mouth sores |
| Cardiovascular | Negative | No chest pain, palpitations, or leg swelling |
| Respiratory | Negative | No cough or breathlessness |
| Breast | Negative | No lump, pain, or skin change in the left breast or on the right chest wall |
| Gastrointestinal | Negative | Regular bowels; no blood in the stool |
| Genitourinary | Negative | No abnormal vaginal bleeding, discharge, or pelvic pain; no urinary symptoms |
| Musculoskeletal | Negative | No bone pain; full use of the right arm |
| Integumentary | Negative | Mastectomy scar comfortable; no new skin lesions |
| Neurological | Negative | No headaches or numbness |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |
| Endocrine | Positive | Mild hot flashes, one or two a day; one wakes her about once a week |

13 systems reviewed. **S**

## Current medications

- Tamoxifen 20 mg oral tablet, one tablet by mouth once daily, planned for at least five years **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/74 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 71.5 kg; BMI 25.3 kg/m². All vital signs are synthetic.

Total cholesterol: 182 mg/dL; HDL cholesterol: 64 mg/dL; LDL cholesterol: 98 mg/dL; Triglycerides: 100 mg/dL; HbA1c: 5.4%; PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well-appearing; BMI 25.3 |
| Eyes | Pupils equal and reactive; conjunctivae normal |
| Ears, nose, and throat | Normal |
| Neck | No thyroid enlargement; no cervical or supraclavicular nodes |
| Cardiovascular | Regular rhythm; no murmur; no edema; calves soft and non-tender |
| Respiratory | Clear |
| Breasts and chest wall | Right chest wall flat with a healed transverse scar; no nodules or skin change. Left breast without masses, skin change, or nipple discharge |
| Lymph nodes | No axillary, supraclavicular, or cervical nodes |
| Extremities | Arms equal in size; right shoulder full range of motion |
| Abdomen | Soft; no masses; liver not enlarged |
| Pelvic | External genitalia, vagina, and cervix normal; no blood in the vault; cervical sample taken; uterus normal size; no adnexal masses |
| Skin | No suspicious lesions |
| Psychiatric | Engaged, warm, and direct |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Adult preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression screen negative; AUDIT-C 1. Cervical sample taken as part of the yearly gynecologic assessment advised while she takes tamoxifen. **S**
   - Next preventive visit in one year.
2. **Stage IA right breast cancer, on tamoxifen, no evidence of recurrence** (C50.411). No symptoms or signs of recurrence; left mammogram BI-RADS 1 four weeks ago. Normal periods without abnormal bleeding on tamoxifen. **S**
   - Continue tamoxifen 20 mg daily.
   - Survivorship visit in January; genetic panel result reviewed when it returns.
   - Next left mammogram one year after the last.
3. **Cardiovascular risk**. Total cholesterol 182, HDL 64, LDL 98, triglycerides 100 mg/dL; blood pressure 118/74; non-smoker; HbA1c 5.4%. Low 10-year risk; no statin indicated. **S**
   - Continue current activity and diet.
   - Recheck lipids in five years, or sooner if risk changes.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | Inactivated vaccine given today |
| COVID-19 vaccine, 2026-2027 | Due | Recommended; she will get it at her pharmacy |
| Hepatitis B vaccine | Due | Recommended for adults 19 to 59; series to start at the January visit if the screening test shows no immunity |
| Tetanus booster | Up to date | Tdap seven and a half years ago; next due in about two and a half years |
| Zoster and pneumococcal vaccines | Not indicated | Recommended from age 50; tamoxifen is not immunosuppressive |
| Breast cancer screening | Not indicated | Replaced by surveillance: yearly diagnostic mammogram of the left breast, last done four weeks ago |
| Cervical cancer screening | Completed today | Cytology with HPV co-testing; last screening more than five years ago; result pending |
| Colorectal cancer screening | Ordered | Recommended from 45; after discussing the options she chose a yearly fecal immunochemical test; kit given |
| Hepatitis B, hepatitis C, and HIV screening | Ordered | One-time screening; no prior result on record; drawn today, results pending |
| Cholesterol screening and statin decision | Completed today | LDL 98 mg/dL; low 10-year risk; no statin |
| Diabetes screening | Completed today | HbA1c 5.4% (BMI 25.3) |
| Blood pressure screening | Completed today | 118/74 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 1, negative |
| Intimate partner violence screening | Completed today | Negative; feels safe at home |
| Tobacco use | Completed today | Never smoker |
| Bone density testing | Not indicated | Premenopausal on tamoxifen alone; calcium and vitamin D from diet and weight-bearing exercise advised |
| Physical activity and diet counseling | Completed today | Walking about 200 minutes a week; add strength exercise twice a week |

## Advance care planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She has named a health care agent, and a written health care directive form was given for her to complete at home. She wants complete and frank information about her health and to make her own decisions. No specific treatment preferences were recorded today; the discussion will continue at next year's visit or sooner if her health changes. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Cervical screening, hepatitis B, hepatitis C, and HIV results by portal message. Fecal immunochemical test returned by mail. Survivorship visit in January with the genetic panel result. Next preventive visit in one year. **S**

